Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

35.37 +0.63 (+1.81%)
Streaming Delayed Price Updated: 2:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
News headline image
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results on Friday, November 14, 2025
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience and Element Biosciences Advance Collaboration with Launch of New Trinity Freestyle™ Sequencing Workflow for the AVITI™ System
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at Baird 2025 Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Collaborates with Synthetic Design Lab
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Appoints Trynka Shineman Blake to Board of Directors
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2025 Third Quarter Financial Results on Monday, August 4, 2025
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Expands Express Delivery Turnaround Time to All Gene Fragments Regardless of Format
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience and Ginkgo Bioworks Revise Collaboration
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Spins Out DNA Data Storage as Independent Company
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.